thiophenes has been researched along with Depressive Disorder in 91 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.20) | 18.2507 |
| 2000's | 52 (57.14) | 29.6817 |
| 2010's | 35 (38.46) | 24.3611 |
| 2020's | 2 (2.20) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, E; Hamilton, A; Malhi, GS; Morris, G | 1 |
| Espay, AJ; Gupta, HV; Sharma, VD | 1 |
| Pitchot, W | 1 |
| Han, SI; Jeon, YW; Lee, KU; Park, EJ; Wang, SM | 1 |
| Itoh, M; Masuda, R; Suzuki, T | 1 |
| Chang, JP; Chi, MH; Chiu, YN; Gau, SS; Shang, CY; Tsai, WC | 1 |
| Berk, M; Craig Nelson, J; Deberdt, W; Dodd, S; Eriksson, E; Kelin, K; Zhang, Q | 1 |
| Becker, T; Kösters, M; Staudigl, L | 1 |
| Lieb, K | 1 |
| Greig, SL | 1 |
| Fan, SY; He, XH; Jin, ZL; Li, NM; Li, Y; Li, YF; Xue, R; Yuan, L; Zhang, TT; Zhang, YZ; Zheng, AP; Zhong, BH | 1 |
| Antoniou, K; Hyphantis, TN; Mavreas, V; Mouka, V; Peritogiannis, V | 1 |
| Allgulander, C; Nutt, D | 1 |
| Acharya, N; Heinloth, AN; Kuritzky, L; Regev, A; Robinson, M; Strombom, I; Wernicke, JF; Wohlreich, MM | 1 |
| Wise, TN | 1 |
| Edel, MA; Hubert, C; Juckel, G; Rudel, A | 1 |
| Bobrova, MV; Listopadov, IuI; Rzheusskaia, GV; Umrudina, AG | 1 |
| De Fruyt, J; Demyttenaere, K | 1 |
| Arellano, J; Baird, J; Benedict, A; De Cock, E | 1 |
| Fassino, S; Gastaldi, F; Lavagnino, L; Leombruni, P; Vasile, A | 1 |
| Hiemke, C; Pfuhlmann, B; Vogel, F; Waldschmitt, C | 1 |
| Fernandez-Fernandez, FJ; Fuente-Aguado, Jde L; Montero-Tinnirello, J; Rodriguez-Pecci, MS | 1 |
| Arnheim, K | 1 |
| Apazoglou, K; Farley, S; Giros, B; Tzavara, ET; Witkin, JM | 1 |
| Dharia, S; Fijal, B; Heinloth, AN; Houston, JP; Perlis, RH | 1 |
| Duman, RS; Ferguson, D; Koo, JW; Nestler, EJ; Russo, SJ | 1 |
| Del Casale, A; Girardi, P; Innamorati, M; Lester, D; Mancini, M; Pompili, M; Serafini, G; Tatarelli, R | 1 |
| Himmerich, H; Kirkby, KC; Kürstein, B; Steffenhagen, N | 1 |
| Boeker, H; Himmighoffen, H; Seifritz, E | 1 |
| Guerdjikova, AI; Hudson, JI; Keck, PE; McCoy, J; McElroy, SL; Mori, N; Nelson, EB; Winstanley, EL | 1 |
| Bandini, F; Cestari, L; Colicchio, S; Cordano, C; Escelsior, A; Fornaro, M; Martino, M; Ogliastro, C; Perugi, G; Rocchi, G | 1 |
| Atmaca, M; Işık, U; Korkmaz, S; Kuloğlu, M; Sağlam, S | 1 |
| Buschmann, H; Washeim, HA | 1 |
| Finkelmeyer, A; Grözinger, M; Paulzen, M | 1 |
| Patel, TA; Rastogi, R; Swarm, RA | 1 |
| Hegerl, U; Hundemer, HP; Linden, M; Mergl, R; Quail, D; Schneider, E | 1 |
| Seeger, J; Strombom, I; Turnbull, B; Xue, F; Zhu, S | 1 |
| Bertol, E; Gualco, B; Mari, F; Rensi, R | 1 |
| Saito, M; Someya, T; Suzuki, Y | 1 |
| Boere, J; De Vry, J; Engel, S; Kenis, G; Melnick, L; Prickaerts, J; Quinton, MS; Schreiber, R | 1 |
| Härmark, L; van Grootheest, K; van Puijenbroek, E | 1 |
| Batchelder, ST; Black, SR; Chen, Y; Deliyannides, DA; Hellerstein, DJ; McGrath, PJ; O'Shea, D; Stewart, JW; Withers, A | 1 |
| Albayrak, Y; Ekinci, O | 1 |
| Lai, CH | 1 |
| Diav-Citrin, O; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Malm, H; Panchaud, A; Pistelli, A; Smart, K; Stephens, S; Taylor, T; Vial, T; Yates, L | 1 |
| Cavanaugh, JE; Karpa, KD; Lakoski, JM | 1 |
| Fishbain, DA | 1 |
| Briley, M | 1 |
| Stewart, DE | 1 |
| Dawson, LA; Li, P | 1 |
| Li, X; Need, AB; Skolnick, P; Witkin, JM | 1 |
| Schatzberg, AF | 1 |
| Beedle, EE; Bymaster, FP; Findlay, J; Gallagher, PT; Krushinski, JH; Mitchell, S; Robertson, DW; Thompson, DC; Wallace, L; Wong, DT | 1 |
| Bailey, KP | 1 |
| Hirschfeld, RM; Vornik, LA | 1 |
| Detke, MJ; Fava, M; Mallinckrodt, CH; Watkin, JG; Wohlreich, MM | 1 |
| Gonzales, JS; Watkin, JG; Wohlreich, MM | 1 |
| Delgado, PL | 1 |
| Jost, W; Marsalek, P | 1 |
| Demitrack, MA | 1 |
| Rabasseda, X | 1 |
| Preskorn, SH | 1 |
| Liu, C; Mallinckrodt, CH; Raskin, J; Watkin, JG; Wohlreich, MM | 1 |
| Obenchain, RL; Robinson, RL; Swindle, RW | 1 |
| Botts, S | 1 |
| Gayken, J; Haight, R; Westanmo, AD | 1 |
| Ammar, H; Malani, AK | 1 |
| Clemens, JW; Detke, MJ; Gilaberte, I; Huckins, SA; Montejo, AL; Montgomery, SA; Perahia, DG; Wang, F; Wiltse, CG | 1 |
| Bech, P; Kajdasz, DK; Porsdal, V | 1 |
| Desaiah, D; Perahia, DG; Pritchett, YL; Raskin, J | 1 |
| Tobin, ML | 1 |
| De Las Cuevas, C; Sanz, EJ | 1 |
| Greist, JH; Mallinckrodt, CH; Nierenberg, AA; Prakash, A; Sambunaris, A; Tollefson, GD; Wohlreich, MM | 1 |
| O'Neill, MJ; Witkin, JM | 1 |
| Spielmans, GI | 1 |
| Leonard, BE | 1 |
| Berk, M; Birkett, M; du Plessis, AD; Richardt, D | 1 |
| Pitsikas, N | 1 |
| Fava, M | 1 |
| Demitrack, MA; Detke, MJ; Goldstein, DJ; Hayes, JR; Lu, Y | 1 |
| Bymaster, FP; Wong, DT | 1 |
31 review(s) available for thiophenes and Depressive Disorder
| Article | Year |
|---|---|
A New Paradigm for Achieving a Rapid Antidepressant Response.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Ketamine; Quinolones; Thiophenes | 2020 |
Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo.
Topics: Adult; Aged; Depression; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2014 |
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].
Topics: Acetamides; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; General Practice; Germany; Guideline Adherence; Humans; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Brexpiprazole: First Global Approval.
Topics: Depressive Disorder; Drug Approval; Humans; Internationality; Molecular Structure; Quinolones; Schizophrenia; Thiophenes | 2015 |
Answers to the most common questions about the hepatic safety profile of duloxetine.
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Approval; Drug Labeling; Duloxetine Hydrochloride; Humans; Liver Diseases; Risk Assessment; Thiophenes; United States | 2008 |
Efficacy, tolerability, and safety of duloxetine.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2005 |
Quality of life measurement in antidepressant trials. Is there an added value?
Topics: Activities of Daily Living; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Duloxetine Hydrochloride; Humans; Personality Inventory; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Reproducibility of Results; Thiophenes | 2009 |
Case scenario: opioid association with serotonin syndrome: implications to the practitioners.
Topics: Analgesics, Opioid; Antidepressive Agents, Tricyclic; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Depressive Disorder; Desipramine; Drug Interactions; Duloxetine Hydrochloride; Fentanyl; Humans; Male; Methadone; Middle Aged; Oxycodone; Polypharmacy; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sulfonamides; Thiophenes; Transdermal Patch | 2011 |
Duloxetine pharmacology: profile of a dual monoamine modulator.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain; Clinical Trials as Topic; Depressive Disorder; Duloxetine Hydrochloride; Electrophysiology; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2002 |
New hope in the treatment of painful symptoms in depression.
Topics: Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Physical symptoms of depression: unmet needs in special populations.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Child; Comorbidity; Cyclohexanols; Delivery of Health Care; Depressive Disorder; Diagnosis, Differential; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Poverty; Selective Serotonin Reuptake Inhibitors; Sex Factors; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Topics: Adrenergic Uptake Inhibitors; Clinical Trials as Topic; Depressive Disorder; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Norepinephrine; Pain; Selective Serotonin Reuptake Inhibitors; Serotonin; Somatoform Disorders; Thiophenes; Treatment Outcome | 2003 |
Physical symptoms comorbid with depression and the new antidepressant duloxetine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Gastrointestinal Diseases; Humans; Mood Disorders; Norepinephrine; Pain; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2003 |
Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.
Topics: Citalopram; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Humans; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2004 |
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Topics: Adult; Antidepressive Agents; Comorbidity; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Multicenter Studies as Topic; Pain; Pain Measurement; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Thiophenes; Treatment Outcome | 2004 |
Common pathways of depression and pain.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Humans; Sacrococcygeal Region; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence, Stress; Urinary Tract | 2004 |
Can monoamine-based therapies be improved?
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Biogenic Monoamines; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Receptors, Biogenic Amine; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Topics: Adrenergic Uptake Inhibitors; Clinical Trials as Topic; Depressive Disorder; Duloxetine Hydrochloride; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2004 |
Duloxetine.
Topics: Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Humans; Marketing; Thiophenes; United States | 2004 |
Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
Topics: Adult; Cohort Studies; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Severity of Illness Index; Thiophenes; Treatment Outcome | 2005 |
Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Area Under Curve; Depressive Disorder; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Formularies as Topic; Humans; Liver Failure; Randomized Controlled Trials as Topic; Renal Insufficiency; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence | 2005 |
Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Duloxetine Hydrochloride; Europe; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; United States | 2006 |
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Topics: Analgesics; Antidepressive Agents; Chronic Disease; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Thiophenes; Treatment Outcome | 2006 |
Is there a place for duloxetine?
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder; Diabetic Neuropathies; Drug Costs; Drug Interactions; Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2007 |
AMPA receptor potentiators: application for depression and Parkinson's disease.
Topics: Animals; Depressive Disorder; Drug Synergism; Excitatory Amino Acid Agonists; Humans; Parkinson Disease; Receptors, AMPA; Sulfonamides; Thiophenes | 2007 |
Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.
Topics: Adult; Analgesics; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Humans; Pain; Pain Measurement; Paroxetine; Psychophysiologic Disorders; Randomized Controlled Trials as Topic; Somatoform Disorders; Thiophenes; Treatment Outcome | 2008 |
New approaches to the treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Brain; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Dopamine; Duloxetine Hydrochloride; Humans; Receptors, Dopamine; Receptors, GABA; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 1996 |
Duloxetine Eli Lilly & Co.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Contraindications; Depressive Disorder; Drugs, Investigational; Duloxetine Hydrochloride; Humans; Thiophenes; Urinary Incontinence | 2000 |
Somatic symptoms, depression, and antidepressant treatment.
Topics: Antidepressive Agents; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Humans; Personality Inventory; Psychiatric Status Rating Scales; Psychometrics; Somatoform Disorders; Thiophenes; Treatment Outcome | 2002 |
Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2002 |
11 trial(s) available for thiophenes and Depressive Disorder
| Article | Year |
|---|---|
Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial.
Topics: Adult; Bulimia; Depressive Disorder; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Obesity; Pilot Projects; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2009 |
Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Female; Genetic Association Studies; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Thiophenes; Treatment Outcome | 2010 |
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Retrospective Studies; Thiophenes; Venlafaxine Hydrochloride | 2010 |
Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Binge-Eating Disorder; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Thiophenes; Treatment Outcome | 2012 |
Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Drug Monitoring; Duloxetine Hydrochloride; Female; Humans; Internet; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Thiophenes; Young Adult | 2013 |
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Topics: Adult; Aged; Antidepressive Agents; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Inventory; Prospective Studies; Psychometrics; Social Adjustment; Temperament; Thiophenes; Young Adult | 2012 |
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Topics: Adult; Antidepressive Agents; Comorbidity; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Multicenter Studies as Topic; Pain; Pain Measurement; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Thiophenes; Treatment Outcome | 2004 |
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study.
Topics: Adult; Analysis of Variance; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2006 |
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Topics: Adult; Antidepressive Agents; Arrhythmias, Cardiac; Citalopram; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Irritable Mood; Male; Middle Aged; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome; Xerostomia | 2007 |
An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study Group.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Thiophenes | 1997 |
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Pain Measurement; Placebos; Psychiatric Status Rating Scales; Somatoform Disorders; Thiophenes; Treatment Outcome | 2002 |
50 other study(ies) available for thiophenes and Depressive Disorder
| Article | Year |
|---|---|
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aripiprazole; Clonazepam; Deprescriptions; Depressive Disorder; Drug Substitution; GABA Modulators; Humans; Male; Parkinsonian Disorders; Pelvis; Propranolol; Quinolones; Serotonin Agents; Tardive Dyskinesia; Tetrabenazine; Thiophenes; Treatment Failure; Valine | 2020 |
[Is there a place for the physician's hopelesness in the treatment of depression?].
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Physician's Role; Piperazines; Quinolones; Remission Induction; Risk Factors; Thiophenes; Treatment Outcome | 2013 |
Severe urinary retention requiring urinary catheterization associated with combined treatment of depression with duloxetine and quetiapine.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Male; Quetiapine Fumarate; Thiophenes; Urinary Catheterization; Urinary Retention | 2013 |
[Duloxetine for chronic pain management: pharmacology and clinical use].
Topics: Adrenergic Uptake Inhibitors; Chronic Pain; Depression; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Thiophenes | 2013 |
Serotonin-norepinephrine reuptake inhibitor-associated mixed episode in an adolescent with schizoaffective disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Bipolar Disorder; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2014 |
[What will not be publicized].
Topics: Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Germany; Humans; Publication Bias; Randomized Controlled Trials as Topic; Thiophenes | 2014 |
Pharmacokinetic profiles contribute to the differences in behavioral pharmacology of 071031B enantiomers as novel serotonin and norepinephrine reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodioxoles; Depression; Depressive Disorder; Duloxetine Hydrochloride; Male; Mice; Mice, Inbred ICR; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Swimming; Thiophenes | 2017 |
Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching.
Topics: Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2009 |
Wine and drug evaluations: lessons on making comparisons of noninferiority.
Topics: Anxiety Disorders; Cross-Cultural Comparison; Cyclohexanols; Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Europe; Humans; Placebo Effect; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride; Wine | 2008 |
[Combination of dialectic and behavioral therapy (DBT) and duloxetin in kleptomania].
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Male; Middle Aged; Patient Admission; Personality Disorders; Psychotherapy, Group; Thiophenes | 2009 |
[Cymbalta (duloxetine) in the treatment of anxiety-depressive disorders in patients with discirculatory encephalopathy].
Topics: Adult; Aged; Antidepressive Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Syndrome; Thiophenes; Treatment Outcome | 2009 |
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
Topics: Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Duloxetine Hydrochloride; Health Care Costs; Humans; Mianserin; Mirtazapine; Prevalence; Quality of Life; Recurrence; Remission Induction; Scotland; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2010 |
Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Chromatography, High Pressure Liquid; Depressive Disorder; Dose-Response Relationship, Drug; Drug Monitoring; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; ROC Curve; Severity of Illness Index; Spectrum Analysis; Thiophenes; Treatment Outcome; Ultraviolet Rays; Young Adult | 2009 |
[Mirtazapine-associated hepatotoxicity].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Drug Interactions; Duloxetine Hydrochloride; Humans; Kidney Failure, Chronic; Male; Mianserin; Middle Aged; Mirtazapine; Nephrosclerosis; Thiophenes | 2010 |
[Psycho- and pharmacotherapy of depressions. So you combine correctly].
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Humans; Mianserin; Middle Aged; Mirtazapine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodiazepines; Chronic Disease; Depression; Depressive Disorder; Disease Models, Animal; Emotions; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred BALB C; Motor Activity; Receptors, AMPA; Stress, Psychological; Sulfonamides; Thiophenes | 2010 |
Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior.
Topics: Animals; Cell Proliferation; Cells, Cultured; Depressive Disorder; Female; Hippocampus; Interleukin-1beta; Male; Mice; Mice, Transgenic; Neurogenesis; Neurons; NF-kappa B; Phenylenediamines; Rats; Rats, Sprague-Dawley; Restraint, Physical; Signal Transduction; Stem Cells; Stress, Psychological; Thiophenes | 2010 |
[Focus on treatment success of depressed patients. Early and significant pain reduction improves chances for remission].
Topics: Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Humans; Long-Term Care; Pain; Thiophenes | 2010 |
Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy.
Topics: Aged; Antimanic Agents; Depressive Disorder; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Hospitalization; Humans; Lithium Carbonate; Male; Outpatients; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2011 |
Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
Topics: Benzodiazepines; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Olanzapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiophenes | 2011 |
Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?
Topics: Adult; Antidepressive Agents; Case-Control Studies; Depression; Depressive Disorder; Depressive Disorder, Major; Dopamine; Duloxetine Hydrochloride; Electroretinography; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Thiophenes; Treatment Outcome | 2011 |
Galactorrhea during duloxetine treatment: a case report.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Female; Galactorrhea; Humans; Psychometrics; Thiophenes | 2011 |
[Interview with Dr. Heike-Ariane Washeim, Zirndorf, and Dr. Heiner Buschmann, Übach-Palenberg (interview by Abdol A. Ameri)].
Topics: Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; General Practice; Humans; Somatoform Disorders; Thiophenes | 2011 |
[Because depression also hurts: duloxetine can help patients return to vitality].
Topics: Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Humans; Pain; Pain Measurement; Quality of Life; Somatoform Disorders; Thiophenes | 2011 |
Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; International Classification of Diseases; Male; Middle Aged; Retrospective Studies; Thiophenes | 2011 |
Does pain improve earlier than mood in depressed patients with painful physical symptoms treated with duloxetine?
Topics: Adult; Affect; Antidepressive Agents; Chronic Pain; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Surveys and Questionnaires; Thiophenes; Time Factors | 2012 |
Treatment with duloxetine in adults and the incidence of cardiovascular events.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Electrocardiography; Female; Follow-Up Studies; Humans; Insurance Claim Review; Male; Propensity Score; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report.
Topics: Acute Disease; Aged; Antidepressive Agents; Blood Pressure; Depressive Disorder; Duloxetine Hydrochloride; Fatal Outcome; Female; Heart Arrest; Heart Rate; Humans; Pulmonary Embolism; Thiophenes | 2012 |
Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Delirium; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Thiophenes | 2012 |
Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex.
Topics: Animals; Antidepressive Agents; Astrocytes; Astrocytoma; Aza Compounds; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Depressive Disorder; Duloxetine Hydrochloride; Hippocampus; Male; Mice; Neurons; Neurotransmitter Uptake Inhibitors; Prefrontal Cortex; Rats; Rats, Wistar; Thiophenes | 2012 |
Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.
Topics: Depressive Disorder; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Female; Fluvoxamine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2012 |
Increased anterior cingulate regional homogeneity after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients: a case series.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Female; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen; Panic Disorder; Thiophenes; Young Adult | 2012 |
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Case-Control Studies; Cohort Studies; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Trimesters; Prospective Studies; Sample Size; Thiophenes | 2012 |
[Depression also effects the body].
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Duloxetine Hydrochloride; Humans; Randomized Controlled Trials as Topic; Thiophenes | 2003 |
Analgesic effects of antidepressants.
Topics: Analgesics; Antidepressive Agents; Chronic Disease; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; Humans; Pain; Review Literature as Topic; Thiophenes | 2003 |
Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desipramine; Drug Synergism; Extracellular Space; Fluoxetine; Glutamic Acid; Male; Microdialysis; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sulfonamides; Synaptic Transmission; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Enhancement of antidepressant potency by a potentiator of AMPA receptors.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Biogenic Monoamines; Brain; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Male; Mice; Neurons; Receptors, AMPA; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Thiophenes | 2003 |
Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Topics: Antidepressive Agents; Binding Sites; Clinical Trials as Topic; Depressive Disorder; Duloxetine Hydrochloride; Humans; Kinetics; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Thiophenes | 2003 |
[18 million sick days due to depressive illnesses. New prospects in therapy of depression].
Topics: Absenteeism; Antidepressive Agents; Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Diagnosis, Differential; Duloxetine Hydrochloride; Germany; Humans; Nursing Diagnosis; Somatoform Disorders; Thiophenes | 2003 |
Duloxetine's role in the treatment of depression and associated painful physical symptoms.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Pain; Pain Measurement; Thiophenes; Treatment Outcome | 2004 |
[FDA approval for the antidepressive drug Cymbalta].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Germany; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States | 2004 |
[Duloxetine reduces pain and depression].
Topics: Adrenergic Uptake Inhibitors; Analgesics; Antidepressive Agents; Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Germany; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2004 |
[Change in the point of view].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Humans; Norepinephrine; Nursing Diagnosis; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2005 |
Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance.
Topics: Adult; Antidepressive Agents; Confidence Intervals; Cost-Benefit Analysis; Depressive Disorder; Drug Costs; Drug Therapy; Duloxetine Hydrochloride; Female; Humans; Male; Models, Statistical; Pharmaceutical Preparations; Randomized Controlled Trials as Topic; Research Design; Thiophenes | 2005 |
[Management of psychological symptoms and physical symptoms of depression. Rapid re-integration of patients into employment].
Topics: Antidepressive Agents; Depressive Disorder; Duloxetine Hydrochloride; Humans; Rehabilitation, Vocational; Secondary Prevention; Somatoform Disorders; Thiophenes; Treatment Outcome | 2005 |
[Dual mechanism of action. Remission of physical symptoms].
Topics: Antidepressive Agents; Back Pain; Clinical Trials as Topic; Depressive Disorder; Duloxetine Hydrochloride; Humans; Somatoform Disorders; Thiophenes | 2005 |
Moving beyond balance for a better antidepressant.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Humans; Neurotransmitter Uptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2005 |
Medical management of depression.
Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder; Duloxetine Hydrochloride; Humans; Liver Function Tests; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiophenes; Triazoles | 2006 |
Prescribing update: why choose duloxetine for depression?
Topics: Antidepressive Agents; Choice Behavior; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Drug Prescriptions; Duloxetine Hydrochloride; Humans; Nurse's Role; Nursing Assessment; Patient Selection; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2007 |
Duloxetine-induced excessive disturbing and disabling yawning.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Yawning | 2007 |